Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer

Clinical Endocrinology

Volumn 52, Issue 6, 2000, Pages 765-773

  Doi, Suhail A R ^a,b   Woodhouse, Nicholas J Y ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROIDECTOMY; TREATMENT FAILURE;

COHORT STUDIES; COMBINED MODALITY THERAPY; HUMANS; IODINE RADIOISOTOPES; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; RISK; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT FAILURE;

EID: 0034049757     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01014.x     Document Type: Article

References (38)

1. Angelini, F., Capezzone, M., Cecarelli, C. & Lippi, F. (1997) Comparison among different 1311 activities for ablation of post-surgical thyroid residues. In: Thyroid International, Report of the 24th annual meeting of the European Thyroid Association (ed. G. Hennemann), No. 6-1997, Merck KgaA, Darmstudt, Germany.
2. Bal, C., Padhy, A.K., Jana, S., Pant, G.S. & Basu, A.K. (1996) Prospective randomized clinical trial to evaluate the optimal dose of I-131 for remnant ablation in patients with differentiated thyroid carcinoma. Cancer, 77, 2574-2580.
3. Comtois, R., Theriault, C. & Vecchio, P.D. (1993) Assesment of the efficacy of iodine-131 for thyroid ablation. Journal of Nuclear Medicine, 34, 1927-1930.
4. Creutzig, H. (1987) High or low dose radioiodine ablation of thyroid remnants. European Journal of Nuclear Medicine, 12, 500-502.
5. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188.
6. DeGroot, L.J., Kaplan, E.L., McCormick, M. & Straus, F.H. (1990) Natural history, treatment and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 71 (2), 414-424.
7. DeGroot, L.G. & Reilly, M. (1982) Comparison of 30 and 50 mCi doses of iodine-131 for thyroid ablation. Annals of Internal Medicine, 96, 51-53.
8. Egger, M., Smith, G.D., Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple graphical test. British Medical Journal, 315, 629-634.
9. Goolden, A.W. (1985) The indication for ablating normal thyroid tissue with 131 I in differentiated thyroid cancer. Clinical Endocrinology, 23 (1), 81-86.
10. Greenland, S. & Robins, J.M. (1985) Estimation of a common effect parameter from sparse follow-up data. Biometrics, 41, 55-68.
11. Johansen, K., Woodhouse, N.J.Y. & Odugbesan, O. (1992) Comparison of 1073 Mbq and 3700 Mbq iodine-131 in postoperative ablation of residual thyroid tissue in patient with differentiated thyroid cancer. Journal of Nuclear Medicine, 32, 252-254.
12. Kuni, C.C. & Klingensmith, W.C. (1980) Failure of low doses of I-131 to ablate residual tissue following surgery for thyroid cancer. Radiology, 137, 773-774.
13. Laupacis, A., Sackett, D.L. & Roberts, R.S. (1988) An assessment of clinically useful measures of the consequences of treatment. New England Journal of Medicine, 318, 1728-1733.
14. Leung, S.F., Law, M.W.M. & Ho, S.K.W. (1992) Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases. British Journal of Radiology, 65, 905-909.
15. Lin, J.D., Chao, T.C., Huang, M.J., Weng, H.F. & Tzen, K.Y. (1998a) Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation. American Journal of Clinical Oncology, 21, 77-81.
16. Lin, J.D., Kao, P.F. & Chao, T.C. (1998b) The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. British Journal of Radiology, 71, 307-313.
17. Liu, R.T., Huang, M.J., Huang, H.S., Huang, B.Y., Lin, J.D., Wang, P.W. & Tzen, K.Y. (1987) Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation. Journal of the Formosan Medical Association, 86, 524-528.
18. McCowen, K.D., Alder, R.A., Ghaed, N., Verdon, T. & Hofeldt, F.D. (1976) Low dose radioiodine thyroid ablation in postsurgical patients with thyroid cancer. American Journal of Medicine, 61, 52-58.
19. Mantel, N. & Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute, 22, 719-748.
20. Maxon, H.R. III (1993) The role of 131-I in the treatment of thyroid cancer. Thyroid Today, 16 (2), 1-9.
21. Maxon, H.R. III, Englaro, E.E., Thomas, S.R., Hertzberg, V.S., Hinnefeld, J.D., Chen, L.S., Smith, H., Cummings, D. & Aden, M.D. (1992) Radioiodine-131 therapy for well differentiated thyroid cancer-A quantitative radiation dosimetric approach. Outcome and Validation in 85 Patients. Journal of Nuclear Medicine, 33, 1132-1136.
22. Mazzaferri, E.L. (1991) Treating differentiated thyroid carcinoma: Where do we draw the line? Mayo Clinic Proceedings, 66 (1), 105-111.
23. Mazzaferri, E.L. & Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
24. Ramacciotti, C., Pretorius, H.T., Line, B.R., Goldman, J.M. & Robbins, J. (1982) Ablation of non malignant remnants with low doses of radioiodine iodine. Concise communication. Journal of Nuclear Medicine, 23, 483-489.
25. Ramanna, L., Waxman, A., Brachman, M.B., Tansecu, D.E., Sensel, N. & Braunstein, G.D. (1985) Evaluation of low dose ablation therapy in post-surgical thyroid cancer patients. Clinical Nucleic Medicine, 10, 791-795.
26. Roos, D.E. & Smith, J.G. (1999) Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma - a critique. International Journal of Radiation, Oncology, Biology and Physics, 44, 493-495.
27. Samaan, N.A., Schultz, P.N., Hickey, R.C., Goepfert, H., Haynie, T.P., Johnston, D.A. & Ordonez, N.G. (1992) The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrrospective review of 1599 patients. Journal of Clinical Endocrinology and Metabolism, 75, 714-720.
28. Samuel, A.M. & Rajashekharrao, B. (1994) Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery. Journal of Nuclear Medicine, 35, 1944-1950.
29. Shapiro, S. (1997) Is meta-analysis a valid approach to the evaluation of small effects in observational studies? Journal of Clinical Epidemiology, 50, 223-229.
30. Siddiqui, A.R., Edmondson, J., Wellman, H.N., Hamaker, R.C., Lingeman, R.E., Park, H.M. & Johnston, C.C. (1981) Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma. Clinical Nuclear Medicine, 6, 158-161.
31. Simpson, W.J., Panzarella, T., Carruthers, J.S., Gospodarowicz, M.K. & Sutcliffe, S.B. (1988) Papillary and follicular thyroid cancer. Impact of Treatment in 1578 Patients. International Journal of Radiation, Oncology, Biology and Physics, 14, 1063-1075.
32. Sisson, J.C. (1983) Applying the radioactive eraser I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. Journal of Nuclear Medicine, 24 (8), 743-745.
33. Snyder, J., German, C. & Scanlon, P. (1983) Thyroid remnants ablation: Questionable pursuit of an ill-defined goal. Journal of Nuclear Medicine, 24, 659-665.
34. Tubiana, M., Schlumberger, M., Rougier, P., Laplanche, A., Benhamou, E., Gardet, P., Caillou, B., Travagli, J.P. & Parmentier, C. (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer, 55, 794-804.
35. Utiger, R.D. (1997) Follow-up of palients with thyroid carcinoma. New England Journal of Medicine, 337, 928-930.
36. VanWyngaarden, M. & Mcdougall, I.R. (1996) What is the role of 1100MBq (<30mCi) radioiodine 1311 in the treatment of patients with differentiated thyroid cancer? Nuclear Medicine Communications, 17, 199-207.
37. Vermiglio, F., Violi, M.A., Finocchiaro, M.D., Baldari, S., Castagna, M.G., Moleti, M., Mattina, F., Pio Lo Presti, V., Bonanno, N. & Trimarchi, F. (1999) Short-term effectiveness of low-dose radioiodine ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer. Thyroid, 9, 387-391.
38. Wong, J.B., Kalpan, M.M., Meyer, K.B. & Paukar, S.G. (1990) Ablative radioactive iodine therapy for apparently localized thyroid carcinoma: a decision analytic perspective. Endocrinology and Metabolism Clinics of North America, 19 (3), 741-760.